
Revenue surge masks PAT decline; integration ongoing, base business resilient
JB integration · cost synergies · PAT erosion
BSE: 500420
P/L Snapshot
Q2 FY27 · standalone
Shareholding
Pattern breakdown
P/L Trends
(in crores)

JB integration · cost synergies · PAT erosion

pharmaceuticals · jb chemicals merger · margin compression

JB Chemicals merger · integration accretion · margin expansion
Corporate Events
Board Meeting
A meeting of the Board of Directors will be held on Friday, …
BSE Filing ↗Board Meeting
The Board approved the Audited Standalone Financial Results …
BSE Filing ↗Board Meeting
A meeting of the Board of Directors will be held to consider…
BSE Filing ↗Board Meeting
The 53rd Annual General Meeting (AGM) of Torrent Pharmaceuti…
BSE Filing ↗Board Meeting
Meeting of equity shareholders to consider and approve the p…
BSE Filing ↗Board Meeting
Consider and approve Audited Financial Results, Consider and…
BSE Filing ↗Board Meeting
Consider and approve the Audited Financial Results on Standa…
BSE Filing ↗Board Meeting
Considering and approving the Audited Financial Results on S…
BSE Filing ↗Board Meeting
Considering and approving the Audited Financial Results of t…
BSE Filing ↗Board Meeting
Consider and approve the Audited Financial Results on Standa…
BSE Filing ↗Board Meeting
Consider and approve the Audited Financial Results on Standa…
BSE Filing ↗Board Meeting
Consideration and approval of Audited Financial Results on S…
BSE Filing ↗Board Meeting
Consideration and approval of Audited Financial Results of t…
BSE Filing ↗Board Meeting
Consideration and approval of Audited Financial Results on S…
BSE Filing ↗Board Meeting
Consider and approve Audited Financial Results on Standalone…
BSE Filing ↗